In timely and incisive analysis, our experts parse the latest development issues and events, providing practical solutions to new and emerging challenges.
These episodes are meant to capture the role of luck and privilege in my life, as an American during America’s near-hegemon years, and as a woman in a period of growing opportunities for women.
At a recent CGD staff presentation of our work into COVID-19 vaccines, our colleagues raised a large number of interesting questions, so, we asked our colleagues to send in their questions on the COVID-19 vaccine portfolio.
Today we launch an interactive tool that analyses the COVID-19 vaccine portfolio, and generates estimates about the timelines for the vaccines in the portfolio.
As the world awaits the results of COVID-19 vaccine clinical trials, we have interviewed sixteen vaccine experts from the vaccine industry, academic, and regulatory agencies. Their overall message: the time to prepare is now.